Vacinação contra o vírus do papiloma humano à luz da prevenção quaternária
DOI:
https://doi.org/10.5712/rbmfc14(41)1800Palavras-chave:
Vacinas contra Papillomavirus, Prevenção Primária, Ética Clínica, Prevenção QuaternáriaResumo
Apesar dos benefícios demonstrados, a questão da vacinação massiva contra o HPV ainda está sujeita a intensas discussões e controvérsias. A proteção contra o câncer ainda não está comprovada e precisa de mais tempo para ser precisa sobre a quantificação da redução do câncer do colo do útero. A análise da relevância da vacina contra o HPV é muito complexa devido a vários níveis sobrepostos que devem ser considerados. Os autores analisam muitas das questões éticas, sociológicas, econômicas, políticas e, finalmente, científicas envolvidas nesta análise. A confiança da população nas vacinas foi afetada devido às práticas duvidosas de muitas empresas farmacêuticas. Diante dessa manipulação de informações em escala global, clínicos gerais, família e comunidade se organizaram para lutar contra a incerteza. A prevenção quaternária, conceito apoiado pela Organização Mundial de Médicos de Família, defende a aplicação de procedimentos eticamente aceitáveis nos cuidados médicos. Este artigo de opinião aborda algumas das múltiplas dimensões envolvidas para incentivar a reflexão sobre esta questão.
Downloads
Métricas
Referências
Healey D. The First Vaccine Wars [Internet]. [cited 2018 May 26]. Available from: https://davidhealy.org/the-first-vaccine-wars/
Habakus L, Holland M, eds. Vaccine Epidemic: How Corporate Greed, Biased Science, and Coercive Government Threaten Our Human
Rights, Our Health, and Our Children. New York: Skyhorse Publishing; 2011.
Covello VT, Mumpower J. Risk Analysis and Risk Management: An Historical Perspective. Risk Anal. 1985;5(2):103-20.
https://doi.org/10.1111/j.1539-6924.1985.tb00159.x DOI: https://doi.org/10.1111/j.1539-6924.1985.tb00159.x
Larson HJ, de Figueiredo A, Xiahong Z, Schulz WS, Verger P, Johnston IG, et al. The State of Vaccine Confidence 2016: Global Insights
Through a 67-Country Survey. EBioMedicine. 2016;12:295-301. https://doi.org/10.1016/j.ebiom.2016.08.042 DOI: https://doi.org/10.1016/j.ebiom.2016.08.042
Vinodhini K, Shanmughapriya S, Das BC, Natarajaseenivasan K. Prevalence and risk factors of HPV infection among women from various
provinces of the world. Arch Gynecol Obstet. 2012;285(3):771-7. https://doi.org/10.1007/s00404-011-2155-8 DOI: https://doi.org/10.1007/s00404-011-2155-8
Franco EL, Duarte-Franco E, Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ [Internet]. 2001 Apr 3 [cited 2018 Jun 10];164(7):1017-25. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC80931/
Dijkstra MG, Zummeren M van, Rozendaal L, Kemenade FJ van, Helmerhorst TJM, Snijders PJF, et al. Safety of extending screening
intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands. BMJ [Internet]. 2016 Oct 4 [cited 2018 Jun 10];355:i4924. https://doi.org/10.1136/bmj.i4924 DOI: https://doi.org/10.1136/bmj.i4924
Dumit J. Drugs For Life: How Pharmaceutical Companies Define Our Health. Durham and London. Duke University Press; 2012. DOI: https://doi.org/10.1215/9780822393481
List of largest pharmaceutical settlements. In: Wikipedia [Internet]. 2018 [cited 2018 Jun 10]. Available from: https://en.wikipedia.org/w/
index.php?title=List_of_largest_pharmaceutical_settlements&oldid=837296457
No Gracias. La prescripción off-label, fuera de control (y puede ir a peor) [Internet]. nogracias.eu. 2015 [cited 2018 Jun 10]. Available
from: http://www.nogracias.eu/2015/02/11/la-prescripcion-label-fuera-de-control/
Gøtzsche P. Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare. London: Radcliffe Publishing; 2013.
Lane C. Shyness: How Normal Behavior Became a Sickness. New Haven: Yale University Press; 2008.
Moynihan R, Cassels A. Selling Sickness: How the World’s Biggest Pharmaceutical Companies Are Turning Us All Into Patients. New
York: Nation Books New York; 2005.
Prasad VK, Cifu AS. Ending medical reversal: improving outcomes, saving lives. Baltimore: Johns Hopkins University Press; 2015.
Welch G, Schwartz L, Woloshin S. Overdiagnosed: Making People Sick in the Pursuit of Health. Boston: Beacon Press; 2011.
Sridhar CR. Bad Pharma: How drug companies mislead doctors and harm patients. J Can Res Ther [Internet]. 2013 [cited 2018 Jun
;9:339-40. Available from: http://www.cancerjournal.net/text.asp?2013/9/2/339/113431.
Martínez-Lavín M, Amezcua-Guerra L. Serious adverse events after HPV vaccination: a critical review of randomized trials and
post-marketing case series. Clin Rheumatol. 2017;36(10):2169-78. https://doi.org/10.1007/s10067-017-3768-5 DOI: https://doi.org/10.1007/s10067-017-3768-5
Beppu H, Minaguchi M, Uchide K, Kumamoto K, Sekiguchi M, Yaju Y. Lessons learnt in Japan from adverse reactions to the HPV vaccine:
a medical ethics perspective. Indian J Med Ethics. 2017;2(2):82-8. https://doi.org/10.20529/IJME.2017.021 DOI: https://doi.org/10.20529/IJME.2017.021
Cervarix vaccine issues trigger health notice. The Japan Times Online [Internet]. 2013 Jun 15 [cited 2018 Jun 29]; Available from:
https://www.japantimes.co.jp/news/2013/06/15/national/cervix-vaccine-issues-trigger-health-notice/
Shu-ichi Ikeda, Hineno K, Scheibenbogen C, Heidecke H, Schulze-Forster K, Junker J, et al. Autoantibodies against Autonomic Nerve Receptors in Adolescent Japanese Girls after Immunization with Human Papillomavirus Vaccine. Ann Arthritis Clin Rheumatol. 2019;2(2):1014. [online] Remedypublications.com. Available at: http://www.remedypublications.com/annals-of-arthritis-and-clinicalrheumatology/articles/pdfs_folder/aacr-v2-id1014.pdf?fbclid=IwAR3eySwYrcme_T3sRhpf-JpZqotyr86QdamebiheLncD2NGXk3SJEE. [Accessed 28 Oct. 2019].
Jamoulle M. Quaternary prevention, an answer of family doctors to overmedicalization. Int J Health Policy Manag [Internet]. 2015 Feb 4;
[cited 2018 Jun 29];4(2):61-4. https://doi.org/10.15171/ijhpm.2015.24 DOI: https://doi.org/10.15171/ijhpm.2015.24
Pizzanelli M. NotasL@cas/M@dNotes [Internet].
NotasL@cas/M@dNotes. [cited 2018 Jun 29]. Available from: https://notaslocasmadnotes.
wordpress.com/
Pizzanelli M. Actualización de NotaL@ca: Octubre 2017: Referencias sobre Vacuna HPV / M@dNote: HPV vaccine references – NotasL@
cas/M@dNotes [Internet]. 2017 [cited 2018 Jun 30]. Available from: https://notaslocasmadnotes.wordpress.com/2017/10/16/esta-notalcase-
ha-actualizado-oct-2017-referencias-sobre-vacuna-hpv-mdnote-hpv-vaccine-references/
Jørgensen L, Gøtzsche PC, Jefferson T. The Cochrane HPV vaccine review was incomplete and ignored important evidence of bias. BMJ
Evid Based Med [Internet]. 2018 Oct 1 [cited 2019 May 11];23(5):165-8. https://doi.org/10.1136/bmjebm-2018-111012 DOI: https://doi.org/10.1136/bmjebm-2018-111012
Sociedad Uruguaya de Medicina Familiar y Comunitaria (UY), Grupo de Grupo de Trabajo en Prevención Cuaternaria de Uruguay.
Evaluación crítica sobre la vacuna contra el VPH. – Sumefac [Internet]. SUMEFAC. 2018 [cited 2018 May 26]. Available from: http://
sumefac.com/2018/05/18/evaluacion-critica-sobre-la-vacuna-contra-el-vph/
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Ao submeterem um manuscrito à RBMFC, os autores mantêm a titularidade dos direitos autorais sobre o artigo, e autorizam a RBMFC a publicar esse manuscrito sob a licença Creative Commons Atribuição 4.0 e identificar-se como veículo de sua publicação original.